Armata Pharmaceuticals, Inc. (ARMP)
| Market Cap | $111.21M-59.1% |
| Revenue (ttm) | $7.55M |
| Net Income | -$113.71M |
| EPS | -$4.17 |
| Shares Out | 37.19M |
| PE Ratio | n/a |
| Forward PE | -1.47 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 159,496 |
| Open | $3.84 |
| Previous Close | $3.87 |
| Day's Range | $2.98 - $4.11 |
| 52-Week Range | $2.75 - $14.98 |
| Beta | 1.63 |
| Analysts | Strong Buy |
| Price Target | $17.50(+485.28%) |
| Earnings Date | Nov 12, 2026 |
About ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.
$ARMP stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ARMP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ARMP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ARMP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ARMP Revenue by Segment
| Segment Reporting | $3.27M | 50.77% |
| Grant and award revenue | $3.17M | 49.23% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ARMP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ARMP from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from ARMP’s recent data — informational, not investment advice
What’s Behind the Score
News check: FDA Breakthrough Therapy designation for AP-SA02 is significant positive catalyst; data presentation and conference participation support development momentum.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| BUSM | EA Series Trust - EA Bridgeway Ultra-Small Company Market ETF | 0.14% |
Weight is the stock’s share of each fund’s holdings.
